Colorado CEOs to keynote 2013 Rocky Mountain Life Science Investor and Partnering Conference

Colorado CEOs to keynote 2013 Rocky Mountain Life Science Investor and Partnering Conference

DENVER - Kyle Lefkoff, founder and general partner of Boulder Ventures, will lead a keynote breakfast conversation with CEOs of Colorado's premier publicly-traded pharmaceutical companies during... Read More

By: InnovatioNews Wednesday September 4, 2013 0 comments Tags: Array BioPharma, Boulder Ventures, Clovis Oncology, Denver, Kyle Lefkoff, Patrick Mahaffey, Ron Squarer

Array forms strategic collaboration with Celgene Corp. to license clinical drug candidates

Array forms strategic collaboration with Celgene Corp. to license clinical drug candidates

BOULDER - Array BioPharma Inc . (Nasdaq: ARRY) announced a strategic collaboration with New Jersey-based Celgene Corporation for an Array-invented preclinical development program, targeting a... Read More

By: InnovatioNews Wednesday July 31, 2013 0 comments Tags: Array BioPharma, Boulder, Celgene Corp., Kevin Koch

Array Biopharma and Loxo Oncology announce collaboration agreement

Array Biopharma and Loxo Oncology announce collaboration agreement

BOULDER - New York-based Loxo Oncology, Inc., a biopharmaceutical company recently established and funded by Aisling Capital, and Array BioPharma Inc. (Nasdaq:  ARRY) announced a multi-year... Read More

By: Steve Thursday July 11, 2013 0 comments Tags: Array BioPharma, Boulder, Dennis Purcell, Josh Bilenker, Loxo Oncology, Ron Squarer

Array BioPharma and Global Blood to collaborate on blood disease drug discovery

Array BioPharma and Global Blood to collaborate on blood disease drug discovery

BOULDER - Array BioPharma Inc . (Nasdaq: ARRY) and San Francisco-based Global Blood Therapeutics announced a multi-target drug discovery collaboration agreement to identify small molecule lead... Read More

By: Steve Wednesday March 6, 2013 0 comments Tags: Array BioPharma, Boulder, Kevin Koch

Array BioPharma achieves $8.5 million clinical milestone in Amgen diabetes collaboration

Array BioPharma achieves $8.5 million clinical milestone in Amgen diabetes collaboration

BOULDER - Array BioPharma Inc. (Nasdaq: ARRY) today announced that an $8.5 million milestone was achieved in its collaboration with Amgen after Amgen reached a pre-defined patient enrollment... Read More

By: Steve Thursday July 19, 2012 0 comments Tags: AMG-151, Amgen, Array BioPharma